Refine
Has Fulltext
- yes (13)
Is part of the Bibliography
- yes (13) (remove)
Year of publication
- 2022 (13) (remove)
Document Type
- Journal article (12)
- Preprint (1)
Language
- English (13) (remove)
Keywords
- SARS-CoV-2 (2)
- cisplatin (2)
- cytokinins (2)
- evolution (2)
- mutation (2)
- 3D lung tumor tissue models (1)
- ACKR4 (1)
- AIModules (1)
- AKT (1)
- CD95 (1)
- COVID-19 (1)
- DNA (1)
- DNA storage (1)
- EMT (1)
- H7N9 influenza virus (1)
- HGPS (1)
- IGFBP2 (1)
- KRAS biomarker signatures (1)
- R0 (1)
- RNA secondary structure (1)
- RNA sequencing (1)
- T-cell epitope (1)
- Trypanosoma (1)
- V1–V9 (1)
- V4 (1)
- V7/V8 (1)
- WNT (1)
- adaptation (1)
- aging (1)
- binding pocket (1)
- bioinformatics (1)
- biological activities (1)
- boolean in silico models (1)
- caspase-3 (1)
- comparative sequence analysis (1)
- cosmology (1)
- crystallization (1)
- drug resistance (1)
- emergent gravity (1)
- epitope prediction (1)
- hepatotoxicity (1)
- immune-informatics (1)
- intermediate host (1)
- invasion (1)
- kinetin (1)
- light-gated proteins (1)
- lymphotoxicity (1)
- mammalian system (1)
- molecular docking (1)
- mortality (1)
- nanocellulose (1)
- neuraminidase (1)
- nucleic acid motifs (1)
- omics (1)
- origin (1)
- oxidative stress (1)
- pangolin (1)
- phase transition (1)
- phytohormones (1)
- plant system (1)
- positive selection (1)
- progeria (1)
- protein chip (1)
- qubit (1)
- recombination (1)
- reproductive toxicity (1)
- single-electron transistors (1)
- stemness (1)
- sun exposure (1)
- targeted combination therapy (1)
- transmission (1)
- unified theories (1)
- variable regions (1)
Institute
- Theodor-Boveri-Institut für Biowissenschaften (13)
- Center for Computational and Theoretical Biology (2)
- Comprehensive Cancer Center Mainfranken (1)
- Institut für Experimentelle Biomedizin (1)
- Institut für Informatik (1)
- Institut für Molekulare Infektionsbiologie (1)
- Institut für Virologie und Immunbiologie (1)
- Lehrstuhl für Tissue Engineering und Regenerative Medizin (1)
- Pathologisches Institut (1)
After the recent emergence of SARS-CoV-2 infection, unanswered questions remain related to its evolutionary history, path of transmission or divergence and role of recombination. There is emerging evidence on amino acid substitutions occurring in key residues of the receptor-binding domain of the spike glycoprotein in coronavirus isolates from bat and pangolins. In this article, we summarize our current knowledge on the origin of SARS-CoV-2. We also analyze the host ACE2-interacting residues of the receptor-binding domain of spike glycoprotein in SARS-CoV-2 isolates from bats, and compare it to pangolin SARS-CoV-2 isolates collected from Guangdong province (GD Pangolin-CoV) and Guangxi autonomous regions (GX Pangolin-CoV) of South China. Based on our comparative analysis, we support the view that the Guangdong Pangolins are the intermediate hosts that adapted the SARS-CoV-2 and represented a significant evolutionary link in the path of transmission of SARS-CoV-2 virus. We also discuss the role of intermediate hosts in the origin of Omicron.
The variable regions (V1–V9) of the 18S rDNA are routinely used in barcoding and phylogenetics. In handling these data for trypanosomes, we have noticed a misunderstanding that has apparently taken a life of its own in the literature over the years. In particular, in recent years, when studying the phylogenetic relationship of trypanosomes, the use of V7/V8 was systematically established. However, considering the current numbering system for all other organisms (including other Euglenozoa), V7/V8 was never used. In Maia da Silva et al. [Parasitology 2004, 129, 549–561], V7/V8 was promoted for the first time for trypanosome phylogenetics, and since then, more than 70 publications have replicated this nomenclature and even discussed the benefits of the use of this region in comparison to V4. However, the primers used to amplify the variable region of trypanosomes have actually amplified V4 (concerning the current 18S rDNA numbering system).
Though several previous studies reported the in vitro and in vivo antioxidant effect of kinetin (Kn), details on its action in cisplatin-induced toxicity are still scarce. In this study we evaluated, for the first time, the effects of kinetin in cisplatin (cp)- induced liver and lymphocyte toxicity in rats. Wistar male albino rats were divided into nine groups: (i) the control (C), (ii) groups 2,3 and 4, which received 0.25, 0.5 and 1 mg/kg kinetin for 10 days; (iii) the cisplatin (cp) group, which received a single intraperitoneal injection of CP (7.0 mg/kg); and (iv) groups 6, 7, 8 and 9, which received, for 10 days, 0.25, 0.5 and 1 mg/kg kinetin or 200 mg/kg vitamin C, respectively, and Cp on the fourth day. CP-injected rats showed a significant impairment in biochemical, oxidative stress and inflammatory parameters in hepatic tissue and lymphocytes. PCR showed a profound increase in caspase-3, and a significant decline in AKT gene expression. Intriguingly, Kn treatment restored the biochemical, redox status and inflammatory parameters. Hepatic AKT and caspase-3 expression as well as CD95 levels in lymphocytes were also restored. In conclusion, Kn mitigated oxidative imbalance, inflammation and apoptosis in CP-induced liver and lymphocyte toxicity; therefore, it can be considered as a promising therapy.